▲ 0.98%
prev close
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-06-09 | SNNSmith & Nephew SNATS, Inc. Common Stock | Buy | $1,001 - $15,000 | 232d ago | — |
2025-06-09
Lisa McClain
SNN
Amount
$1,001 - $15,000
Filed
232d ago
Recent News
Powered by Polygon.io
[Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally
Anti-Biofilm Agents Market to Worth Over USD 4.32 Billion By 2035 | Escalating Hospital Infection Rates Drive Urgent Clinical Agent Adoption and Market Growth says Astute Analytica
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000